Bluesight vs Plenful (2026)
Two products sold into the same pharmacy department for different reasons. Bluesight watches controlled substances for diversion, which is a compliance obligation rather than an efficiency project and carries consequences no other pharmacy software does: a substantiated finding can end a career and trigger a mandatory report to a state board. Plenful automates pharmacy operations, with a centre of gravity in drug pricing programme compliance, eligibility screening and rebate reporting, which is where the administrative hours go. A department can and often does need both. The question to press hardest on the diversion side is the false positive rate, because the subject of that analysis is an employee who cannot inspect the profiling behind it, and every false positive is a person investigated for something they did not do.
- Controlled substance diversion detection is the established product in this space, with the market share position and the surveillance depth that comes from years of transaction level analysis.
- The exposure it addresses is a legal and licensure matter as much as an operational one, since a substantiated finding can end a career and trigger mandatory reporting.
- For a health system, diversion monitoring is a compliance obligation rather than an efficiency project.
- It automates pharmacy operations broadly rather than surveillance alone, spanning eligibility screening, rebate reporting and the workflows around drug pricing programme compliance.
- Named health system customers and language models working unstructured record data rather than only structured claims.
- For a pharmacy department whose pain is administrative volume rather than diversion, the workflow automation reaches more of the day.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Bluesight and Plenful are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Bluesight | Plenful |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Administrative Automation |
| Founded | 2011 | Not recorded |
| Headquarters | Alexandria, Virginia, United States | San Francisco, California |
| Website | bluesight.com | plenful.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Bluesight its top capability grade on several axes, including AI Centrality, Model and Technology Transparency and EHR and Interoperability Depth. Set against Plenful, Bluesight grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Plenful its top capability grade on Setting and Specialty Coverage. Set against Bluesight, Plenful grades higher on Setting and Specialty Coverage. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Bluesight or Plenful?
On the axes where the AI Health Index separates them, Bluesight grades higher on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure, and Plenful grades higher on Setting and Specialty Coverage. Bluesight leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Bluesight and Plenful differ most?
The widest separation the AI Health Index records between Bluesight and Plenful is on Model and Technology Transparency, where Bluesight grades A and Plenful grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Bluesight and Plenful grade the same?
The AI Health Index grades Bluesight and Plenful the same on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and Security Certifications and Trust Center. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Bluesight and Plenful not disclosed?
At the last review, at least one of Bluesight and Plenful published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Healthcare Administrative Automation page.
These sit in the same department and solve different problems, so the comparison is about which risk your pharmacy leadership is currently carrying rather than which product is better. Diversion monitoring deserves particular scrutiny on the governance axis because the subject of the analysis is an employee, a substantiated finding can end a career and trigger a mandatory board report, and the behavioural profiling behind it is something the individual cannot inspect.
Plenful publishes no attestation, health privacy statement or business associate terms. Neither publishes an accuracy figure or a false positive rate, which in diversion work is the number that decides how many innocent staff are investigated.